Category: healthcare

Apollomics, the cancer drugmaker, to merge with SPAC Maxpro

Apollomics, the cancer drugmaker, to merge with SPAC Maxpro

September 15, 2022 Healthcare

Cancer pharmaceutical Apollomics –valued at over $1 billion– plans to go public on Nasdaq by merging with SPAC Maxpro Capital Acquisition Corp.

Source: SPACinformer
SPACinformer

SPACinformer

editor

© 2022 All rights reserved. Spacinformer.com (eBuild Ventures)

The information on this website is provided for your convenience only and is not intended to be treated as financial, investment, tax or any other advice. All information is provided "as is", without any warranty. Please read the privacy policy and terms of use. SPACinformer is an affiliate of ENDI Corp.